chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 81.0
Sex: M
Vaccine: FLUA3
Symptoms: Asthenia, Chills, Pain in extremity
Clinical narrative: This is a spontaneous case, reported by healthcare professional (other) to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 721030), concerns an 81-year-old, elderly, male patient. The patient's historical condition was not reported. The patient had no current condition. The patient had been allergic to HYZAAR. On 16-Oct-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, batch number: 179002, route of administration, anatomical location and expiry date: not reported). On the same day of vaccination, the patient experienced chills, extreme arm pain and loss of energy. On an unspecified date, the patient had recovered from the events. The reporter assessed the events as non-serious.
Age: 66.0
Sex: M
Vaccine: FLUA3, PPV
Symptoms: Injection site pain, Pain, Pain in extremity
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 721120) concerning a 66-year-old, elderly male patient. The patient's medical history and concomitant medications were not reported. On 14-Sep-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 178302A, expiry date: not reported). On the same day, the patient was administered with non-company suspect drug PNEUMOVAX (route of administration: intramuscular, anatomical location: left arm, batch number: N019348, dose, expiry date: not reported). On 15-Sep-2017, after 1 day of vaccination, the patient experienced sore and throbbing left arm at site of injection. In addition, the pain was radiating down the arm. At the time of this report, the outcome of the events (pain, pain in extremity and injection site pain) was unknown. The reporter assessed the case as non-serious.
Age: 65.0
Sex: F
Vaccine: FLUA3, PNC13
Symptoms: Chills, Erythema, Injected limb mobility decreased, Injection site erythema, Injection site swelling
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 721130), concerns a 65-year-old, elderly female patient. The patient's historical condition included endometrial cancer (unspecified date) and colon cancer (from an unspecified in 2017 to an unspecified date). The patient's current conditions included, diabetes, hypertension and allergy to penicillin. The concomitant medications included enalapril, hydrochlorothiazide, sertraline and metformin for unknown indications. On 11-Oct-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml (reported as 1), route of administration: intramuscular, anatomical location: right arm, batch number: 178623), expiry date: not reported) and PREVNAR 13 (dose: 1, route of administration: intramuscular, anatomical location: left arm, batch number; R73811 (as reported), expiry date: not reported). On the same day, after vaccination, the patient felt shivering. The patient experienced body aches and fever. Around 10:00 pm (on the same day), the patient experienced nausea and vomiting. On 15-Oct-2017 (Sunday), the symptoms began to subside but a red bump (swelling) appeared on the left arm. The bump began to spread on upper arm and had difficulty in moving arm. On 16-Oct-2017, the patient consulted primary care doctor and was treated with clarithromycin 500 mg for 10 days. On 18-Oct-2017, the patient informed the pharmacy about the events (allergic reaction to vaccine). Pharmacist recommended BENADRYL in case of allergic reaction. No lab data was reported. At the time of this report, the patient was recovering from shivering, body aches, fever, nausea and vomiting, while had not recovered from the events, red bump on the left arm difficulty in moving arm. The reporter assessed this case as non-serious. Case correction received with IRD 20-Mar-2018: The causality of the events injected limb mobility decreased, injection site redness and injection site swelling were changed from related to not related in the event assessment. Case comment was updated accordingly.
Age: 65.0
Sex: F
Vaccine: FLUA3, PNC13
Symptoms: Nausea, Pain, Peripheral swelling, Pyrexia, Vomiting
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 721130), concerns a 65-year-old, elderly female patient. The patient's historical condition included endometrial cancer (unspecified date) and colon cancer (from an unspecified in 2017 to an unspecified date). The patient's current conditions included, diabetes, hypertension and allergy to penicillin. The concomitant medications included enalapril, hydrochlorothiazide, sertraline and metformin for unknown indications. On 11-Oct-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml (reported as 1), route of administration: intramuscular, anatomical location: right arm, batch number: 178623), expiry date: not reported) and PREVNAR 13 (dose: 1, route of administration: intramuscular, anatomical location: left arm, batch number; R73811 (as reported), expiry date: not reported). On the same day, after vaccination, the patient felt shivering. The patient experienced body aches and fever. Around 10:00 pm (on the same day), the patient experienced nausea and vomiting. On 15-Oct-2017 (Sunday), the symptoms began to subside but a red bump (swelling) appeared on the left arm. The bump began to spread on upper arm and had difficulty in moving arm. On 16-Oct-2017, the patient consulted primary care doctor and was treated with clarithromycin 500 mg for 10 days. On 18-Oct-2017, the patient informed the pharmacy about the events (allergic reaction to vaccine). Pharmacist recommended BENADRYL in case of allergic reaction. No lab data was reported. At the time of this report, the patient was recovering from shivering, body aches, fever, nausea and vomiting, while had not recovered from the events, red bump on the left arm difficulty in moving arm. The reporter assessed this case as non-serious. Case correction received with IRD 20-Mar-2018: The causality of the events injected limb mobility decreased, injection site redness and injection site swelling were changed from related to not related in the event assessment. Case comment was updated accordingly.
Age: 75.0
Sex: F
Vaccine: FLUA3, PPV
Symptoms: Erythema, Inflammation, Musculoskeletal pain, Myalgia, Skin warm
Clinical narrative: This is a spontaneous case, reported by healthcare professional (other) to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 721180), concerns a 75-year-old, elderly, female patient. The patient's historical condition, current illness, allergies and concomitant medications were not reported. On 04-Oct-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, anatomical location: left arm, batch number: 179302, route of administration: unknown and expiry date: not reported) and PNEUMOVAX (dose: 1 DF, anatomical location: left arm, batch number: N013541, route of administration: unknown and expiry date: not reported). On the same day, after the vaccinations, the patient experienced muscle and shoulder pain. The patient's shoulder was red, hot and inflamed which lasted for 4 days. On an unspecified date in Oct-2017, the patient had recovered from the events. The reporter assessed the events as non-serious.
Age: 89.0
Sex: F
Vaccine: FLUA3, PPV
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site urticaria, Injection site warmth
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 721195), concerns an 89-year-old elderly female patient. The patient's current condition included diabetes. On 20-Sep-2017, the patient was administered with FLUAD TIV (dose: 0.5ml, route of administration: intramuscular and anatomical location: right arm, batch number: 178602) and PNEUMOVAX (dose: 1 as reported), route of administration: intramuscular and anatomical location: left arm, batch number: N012840). On 21-Sep-2017, the patient experienced injection site reactions such as warmth, pain, redness swelling, almost appeared like hives. The outcome of the events was recovered. The reporter assessed the case as non-serious.
Sex: F
Vaccine: FLUA3, PPV
Symptoms: Erythema, Joint range of motion decreased, Peripheral swelling, Skin warm
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 721341), concerns a 72-year-old, elderly female patient. On 15-Oct-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 179301, expiry date: not reported) and PNEUMOVAX (dose: 1 (as reported), route of administration: intramuscular, anatomical location: left arm, batch number: N022303, expiry date). On 16-Oct-2017, the next day of vaccination, the patient developed red, swollen upper arm and was warm to touch that lasted for 2 days. The patient experienced limited range of motion for 2 days, which reoccurred on third day. On an unspecified date, the patient recovered from the events and no treatment was required. The reporter assessed the case as non-serious.
Age: 65.0
Sex: F
Vaccine: FLUA3, PPV
Symptoms: Arthralgia, Dizziness, Fatigue, Heart rate abnormal, Injected limb mobility decreased
Clinical narrative: This spontaneous case, reported by other non-health care professional to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 721442), concerns a 65-year-old, elderly, female patient. The patient's historical condition included fibromyalgia, interstitial cystitis and osteoarthritis (since on an unspecified date). The patient was allergic to dairy product, sulphites, yellow dyes (10 and 30), red dye 40, macrodantin, DARVON and sulfa drugs (since an unspecified date). The concomitant medications included duloxetine, ELMIRON, nabumetone, glucosamine, chondroitin and hyaluronic acid for an unknown indication (since an unspecified date). On 17-Oct-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number and expiry date: not reported) and on the same day, the patient was administered with non-company suspect product, PNEUMOVAX (route of administration: intramuscular, anatomical location: left arm, dose, batch number and expiry date: not reported). On the same day, after 4 hours of vaccination, the patient's left arm and shoulder muscle were swelled with very painful lump for about 4 in. by 3 in (as reported). The patient also had low grade of fever. After 6 hours of vaccination, the patient was not unable to move her arm or touch her shoulder due to extreme pain. The next day (18-Oct-2017), the patient experienced episodes of dizziness, mild nausea, fatigue, thirst, short term memory problems, joint and muscle pain. Her fever peaked at 100.6 temperature for about 24 hours after the vaccination. All the symptoms peaked about 24 hours after the vaccination. It was reported that, all the events were subsided except the fatigue and short-term memory problems which were continued (but are better as reported) about 44 hours after injection. It was reported that, the patient pulse showed as abnormal. No lab investigations were done to the patient. At the time of the report, the patient had recovered from events (injection site lump, injected limb mobility decreased, dizziness, nausea, pulse abnormal, muscle pain, joint pain, fever, injection site pain and injection site swelling) and the outcome of the events (fatigue and memory impairment) was not recovered. The reporter assessed the case as non-serious.
Age: 65.0
Sex: F
Vaccine: FLUA3, PPV
Symptoms: Injection site mass, Injection site pain, Injection site swelling, Memory impairment, Myalgia
Clinical narrative: This spontaneous case, reported by other non-health care professional to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 721442), concerns a 65-year-old, elderly, female patient. The patient's historical condition included fibromyalgia, interstitial cystitis and osteoarthritis (since on an unspecified date). The patient was allergic to dairy product, sulphites, yellow dyes (10 and 30), red dye 40, macrodantin, DARVON and sulfa drugs (since an unspecified date). The concomitant medications included duloxetine, ELMIRON, nabumetone, glucosamine, chondroitin and hyaluronic acid for an unknown indication (since an unspecified date). On 17-Oct-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number and expiry date: not reported) and on the same day, the patient was administered with non-company suspect product, PNEUMOVAX (route of administration: intramuscular, anatomical location: left arm, dose, batch number and expiry date: not reported). On the same day, after 4 hours of vaccination, the patient's left arm and shoulder muscle were swelled with very painful lump for about 4 in. by 3 in (as reported). The patient also had low grade of fever. After 6 hours of vaccination, the patient was not unable to move her arm or touch her shoulder due to extreme pain. The next day (18-Oct-2017), the patient experienced episodes of dizziness, mild nausea, fatigue, thirst, short term memory problems, joint and muscle pain. Her fever peaked at 100.6 temperature for about 24 hours after the vaccination. All the symptoms peaked about 24 hours after the vaccination. It was reported that, all the events were subsided except the fatigue and short-term memory problems which were continued (but are better as reported) about 44 hours after injection. It was reported that, the patient pulse showed as abnormal. No lab investigations were done to the patient. At the time of the report, the patient had recovered from events (injection site lump, injected limb mobility decreased, dizziness, nausea, pulse abnormal, muscle pain, joint pain, fever, injection site pain and injection site swelling) and the outcome of the events (fatigue and memory impairment) was not recovered. The reporter assessed the case as non-serious.
Age: 65.0
Sex: F
Vaccine: FLUA3, PPV
Symptoms: Nausea, Peripheral swelling, Pulse abnormal, Pyrexia, Thirst
Clinical narrative: This spontaneous case, reported by other non-health care professional to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 721442), concerns a 65-year-old, elderly, female patient. The patient's historical condition included fibromyalgia, interstitial cystitis and osteoarthritis (since on an unspecified date). The patient was allergic to dairy product, sulphites, yellow dyes (10 and 30), red dye 40, macrodantin, DARVON and sulfa drugs (since an unspecified date). The concomitant medications included duloxetine, ELMIRON, nabumetone, glucosamine, chondroitin and hyaluronic acid for an unknown indication (since an unspecified date). On 17-Oct-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number and expiry date: not reported) and on the same day, the patient was administered with non-company suspect product, PNEUMOVAX (route of administration: intramuscular, anatomical location: left arm, dose, batch number and expiry date: not reported). On the same day, after 4 hours of vaccination, the patient's left arm and shoulder muscle were swelled with very painful lump for about 4 in. by 3 in (as reported). The patient also had low grade of fever. After 6 hours of vaccination, the patient was not unable to move her arm or touch her shoulder due to extreme pain. The next day (18-Oct-2017), the patient experienced episodes of dizziness, mild nausea, fatigue, thirst, short term memory problems, joint and muscle pain. Her fever peaked at 100.6 temperature for about 24 hours after the vaccination. All the symptoms peaked about 24 hours after the vaccination. It was reported that, all the events were subsided except the fatigue and short-term memory problems which were continued (but are better as reported) about 44 hours after injection. It was reported that, the patient pulse showed as abnormal. No lab investigations were done to the patient. At the time of the report, the patient had recovered from events (injection site lump, injected limb mobility decreased, dizziness, nausea, pulse abnormal, muscle pain, joint pain, fever, injection site pain and injection site swelling) and the outcome of the events (fatigue and memory impairment) was not recovered. The reporter assessed the case as non-serious.
Age: 75.0
Sex: F
Vaccine: FLUA3
Symptoms: Arthralgia, Confusional state, Injection site joint pain, Memory impairment
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 721612) concerning a 75-year-old, elderly female patient. The had no medical history and no allergies. The patient did not received any concomitant medications. On 11-Oct-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml (reported as 1 dose), route of administration: intramuscular, anatomical location: left arm, batch number: 179103, expiry date: not reported). On the same day of vaccination, the patient felt severe pain in the joints of her hips, knee and shoulders. She was in a state of confusion where she couldn't remember simple things, people or numbers. It was reported that, no lab test was performed. The patient had recovered from all the events (forgetfulness, confusion state, injection site joint pain and joint pain). The reporter assessed the case as non-serious.
Age: 81.0
Sex: F
Vaccine: FLUA3
Symptoms: Contusion, Injection site bruising
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 721674), concerning an 81-year-old, elderly female patient. The patient's historical condition included: high cholesterol. The patient's current condition included: hypertension, asthma and sulfonamide allergy. Concomitant medications included: SINGULAIR, lovastatin and Metoprolol for an unknown indication. On 29-Sep-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 179302, expiry date: not reported). On 30-Sep-2017, after 1 day of vaccination, the patient developed bruise 2 inches below injection site followed by extensive bruising down the arm. The patient had recovered from the events (injection site bruising and bruising). The reporter assessed the case as non-serious.
Age: 65.0
Sex: M
Vaccine: FLUA3, PPV
Symptoms: Pain in extremity, Peripheral swelling
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 721700), concerning a 65-earold, elderly male patient. The patient's medical history and concomitant medications were not reported. On 12-Oct-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, anatomical location: left arm, batch number: 179101, route of administration, expiry date: not reported). On the same day, the patient was administered with non-company suspect drug PNEUMOVAX (anatomical location: right arm, batch number: N019983, dose, route of administration, expiry date: not reported). On the same day, the patient experienced pain or soreness and swelling in right arm for multiple days. The patient had recovered from the events (pain and swelling in arm). The reporter assessed the case as non-serious. Significant case correction received with the IRD 20-Mar-2018: The causality of the events swelling arm and pain in arm was corrected related to not related.
Age: 87.0
Sex: F
Vaccine: FLUA3
Symptoms: Injected limb mobility decreased, Injection site pain, Loss of personal independence in daily activities, Pyrexia
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 721757), concerns an 87-year-old, elderly female patient. On 20-Sep-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: injected (reported as SYR), anatomical location: right arm, batch number, expiry date: not reported). On 21-Sep-2017, after one day of vaccination, the patient developed severe pain in right shoulder and upper arm (reported as ongoing). The patient was unable to use the right arm to do usual daily life activities (for 3 weeks). The patient had low-grade fever through 08-Oct-2017. At the time of the report, the patient was not recovered from the events. The reporter assessed the case as non-serious.
Age: 64.0
Sex: M
Vaccine: FLUA3
Symptoms: No adverse event, Wrong drug administered
Clinical narrative: This spontaneous case, reported by a health care professional (other) to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 721815), concerns a 64-year-old adult male patient. The patient was allergic to shrimps. On 01-Oct-2017, the patient was administered with FLUAD (TIV) instead of FLUARIX (dose: 0.5ml, route of administration: intramuscular, anatomical location: left arm, batch number: 179402, expiry date: not reported). It was reported that, the patient did not experience any adverse events after vaccination. The reporter assessed this case as non-serious.
Age: 75.0
Sex: F
Vaccine: FLUA3
Symptoms: Contusion, Haematoma
Clinical narrative: This spontaneous case, reported by health care professional (other) to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 721958), concerns a 75-year-old, elderly, female patient. The patient's medical history, allergies and the concomitant medications were not reported. On 18-Oct-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml (1 as reported), route of administration: intramuscular, anatomical location: right arm, batch number: 179501 and expiry date: not reported). On 19-Oct-2017, after 2 days of vaccination, the patient experienced contusion and haematoma to the left arm and went to physician. At the time of the report, the outcome of the events (contusion and hematoma) was unknown. The reporter assessed the case as non-serious.
Sex: F
Vaccine: FLUA3
Symptoms: Peripheral swelling, Rash, Rash pruritic
Clinical narrative: This spontaneous case, reported by health care professional (other) to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 721991), concerns a 74-year-old, elderly, female patient. The patient's current condition included hangnail infection on arm (from an unspecified date), allergies and concomitant medications were unknown. On 22-Oct-2017, the patient was administered with FLUAD (TIV) dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 179523 and expiry date: not reported). On 23-Oct-2017, after 2 days of vaccination, the patient woke up with swollen and itchy arm with a rash. It was reported that, BENADRYL did not help her, the rash goes around her elbow to wrist. At the time of the report, the outcome of the events (swollen arm, itchy rash and rash) was unknown. The reporter assessed the case as non-serious.
Age: 72.0
Sex: M
Vaccine: FLUA3
Symptoms: Condition aggravated, Headache, Pharyngeal oedema, Sleep apnoea syndrome, Tinnitus
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 722102), concerns an 72-year-old elderly male patient. The patient's current condition included sleep apnea (since an unspecified date in 2005), type 2 diabetes (since an unspecified date in Dec-2015). The patient's concomitant medications included Metformin, LEVOTHROID for an unknown indication. On 20-Oct-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration, intramuscular, anatomical location: left arm, batch number: not reported). On 21-Oct-2017, approximately 28 hours after vaccination, the patient was about to go to bed at friend's house, the patient developed swollen throat, and a headache ensued which was severe that led to sleep apnea episodes that awoke him. It was stated that, the patient had to drive over an hour in the middle of the night to get back home so that, he could sleep with CPAP (continuous positive airway pressure) to prevent further episodes. Previously, the patient was able to sleep elsewhere without CPAP. On the following morning, the patient throat was still swollen, the headache was worse and experienced ringing in the ears. Subsequently, 52 hours later, the patient's throat was still swollen and ringing in the ears, however the patient has worked. The patient had not yet recovered from the events. The reporter assessed the case as non-serious. Significant case correction received with IRD 20-Mar-2018: The as determined causality of the event (throat swelling) was corrected from unassessable to related.
Age: 80.0
Sex: M
Vaccine: FLUA3
Symptoms: Blood pressure fluctuation, Blood pressure increased
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 722262) concerns an 80-year-old, elderly male patient. The patient had no side-effects or any problem with registered vaccine. The patient had no relevant medical history or current illness. On 03-Oct-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: unknown, anatomical location: unknown, batch number: 179102, expiry date: not reported). On 04-Oct-2017 (after12 hours of vaccination), the patient blood pressure (BP) raised to 180/95. BP increased and decreased for 3 to 4 days. The patient visited physician and took medications. The patient's BP was normalized within 6 to 7 days. At the patient time of this report, the patient had recovered from the events. The reporter assessed the case as non-serious.
Age: 78.0
Sex: M
Vaccine: FLUA3, PPV
Symptoms: Erythema, Lethargy, Musculoskeletal pain, Neck pain, Pruritus
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 722308), concerns an 78-year-old, elderly male patient. On 19-Oct-2017 (Thursday), the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: unknown, batch number: 179303, expiry date: not reported) and PNEUMOVAX (dose: unknown, route of administration: intramuscular, anatomical location: unknown, batch number: N012840 (as reported), expiry date: not reported). On 20-Oct-2017 (Friday morning), the patient experienced itching. On Saturday, the patient developed redness in the inner arm and extend 3 inches past elbow (felt like smirked), lousy shoulder/neck aching and lethargic. The outcome of the events was unknown. At the time of the report, the patient had not recovered from the events. The reporter assessed the case as non-serious.
Age: 68.0
Sex: F
Vaccine: FLUA3, PPV
Symptoms: Cellulitis, Injection site reaction, Rash
Clinical narrative: This is a spontaneous case, reported by healthcare professional (other) to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS Id: 722327), concerns a 68-year-old, elderly, female patient. The patient's historical condition included hyperlipidemia and osteoporosis (unspecified date). The patient had no current illness and no known allergies. Concomitant medications were not reported. On 15-Oct-2017, at 11:35 am, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, anatomical location: left deltoid, batch number: 179502, route of administration: unknown and expiry date: not reported) and PNEUMOCAX (dose: 1 DF, anatomical location: left deltoid, batch number: N020502, route of administration: unknown and expiry date: not reported). On 17-Oct-2017, after 2 days of vaccination (reported as on Tuesday), the patient developed a painful rash below injection site. On the same day, patient went to the clinic and was diagnosed with cellulitis. The patient was prescribed with Cephalexin (500 mg). On 18-Oct-2017, at 09:20 am, patient was called and stated that she felt better. On an unspecified date in Oct-2017, the patient had recovered from the event. The reporter assessed the event as non-serious.
Sex: F
Vaccine: FLUA3
Symptoms: Injection site bruising, Injection site erythema, Injection site nodule, Injection site pain
Clinical narrative: This spontaneous case, reported by health care professional (other) to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 722346), concerns a 71-year-old, elderly, female patient. The patient's medical history and concomitant medications were not reported. On 17-Oct-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 179302 and expiry date: not reported). On 20-Oct-2017, after 4 days of vaccination the patient experienced extreme soreness, knot, redness and bruise at injection site. It was reported that, the patient still bruised and soreness. At the time of the report, the patient had recovered from of the events (injection site pain and injection site bruising) and had not recovered from events (injection site redness and injection site nodule). The reporter assessed the case as non-serious.
Age: 71.0
Sex: F
Vaccine: FLUA3, PPV
Symptoms: Chills, Erythema, Pain in extremity, Peripheral swelling, Pyrexia
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 722400), concerns an 71-year-old elderly female patient. The patient's current condition included diabetes, historical conditions included insomnia and depression. The patient was allergic to aspirin, macrobid and sulfa. On 20-Oct-2017, the patient was administered with FLUAD (dose: 0.5 ml (unk as reported), route of administration: intramuscular and anatomical location: left arm, batch number: 179502) and PNEUMOVAX (dose: 1 as reported, route of administration: intramuscular, anatomical location: left arm, batch number: N019348 as reported). On the same day, the patient experienced sore arm and chills for a couple of nights. Subsequently, the patient's left arm was red and swollen which seemed to spread downwards. It was not clear that the events occurred from PNEUMOVAX or FLUAD. On 23-Oct-2017, in the morning, a call was made to pharmacy and the pharmacist suggested to apply ice, aloe vera gel on the affected area, additionally BENADRYL was continued. On 24-Oct-2017, in the morning, the patient's husband reported that the patient's arm was still red but not improved. A night before, the patient experienced fever and then felt better. At the time of this report, the patient recovered from the events. The reporter assessed the case as non-serious.
Sex: F
Vaccine: FLUA3
Symptoms: Arthralgia, Injection site pain, Muscular weakness
Clinical narrative: This spontaneous case, reported by other non-health professional to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 722433), concerns a 71-year-old female patient. The patient's current conditions included high blood pressure, kidney failure, diabetic (reported as for 14 years, under control). The patient's concomitant medications included COZAAR, HTCZ and aspirin. On 09-Sep-2017, the patient was administered with FLUAD TIV (dose: 0.5ml, route of administration: injection (SYR as reported), anatomical location: right arm, batch number: not reported). On 21-Sep-2017, 13 days after vaccination the patient experienced pain in both the knees, weakness in legs, pain in the shoulder just in the right side (reported as just one the right one). The patient felt hard to lie down sometimes. The patient doesn't have a primary right. She left the network, in the process of choosing one. The patient took pain relievers just over the counter to ease the pain. The outcome of the events had not yet recovered. The reporter assessed the case as non-serious.
Age: 69.0
Sex: M
Vaccine: FLUA3
Symptoms: Cough, Culture throat negative, Malaise, Oropharyngeal pain, Pain
Clinical narrative: This spontaneous case, reported by other health care professional to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 722603), concerns a 69-year-old, elderly, male patient. The patient's current condition included high blood pressure and the patient was allergic to dairy products (since an unspecified date) and had no other current illnesses. The concomitant medications included pravastatin, benazepril, hydrochlorothiazide and naproxen (since an unspecified date). On 05-Oct-2017, the patient was administered with FLUAD (dose: 0.5 ml (1 as reported), route of administration: injection (SYR), anatomical location: right arm, batch number (material number: 70461-0002-01 (as reported), batch number and expiry date: not reported). On 07-Oct-2017, after 2 days of vaccination, the patient woke up with cough and sore throat. The patient felt pure sickness and experienced fever and achiness. After 14 days of sickness, the patient still had bad cough. On 14-Oct-2017, the throat culture was performed, results were found to be negative, but the throat was very raw. On an unspecified date in 2017, the patient went to physician. At the time of the report, the patient had not recovered from cough and the outcome of the events sore throat, ache, raw throat, sickness and fever was unknown. The reporter assessed the case as non-serious. Non-significant case correction received 20-Mar-2018: Typo error (batch numner was changed to batch number), the word 'event' was removed before cough.
Age: 69.0
Sex: M
Vaccine: FLUA3
Symptoms: Pyrexia, Throat irritation
Clinical narrative: This spontaneous case, reported by other health care professional to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 722603), concerns a 69-year-old, elderly, male patient. The patient's current condition included high blood pressure and the patient was allergic to dairy products (since an unspecified date) and had no other current illnesses. The concomitant medications included pravastatin, benazepril, hydrochlorothiazide and naproxen (since an unspecified date). On 05-Oct-2017, the patient was administered with FLUAD (dose: 0.5 ml (1 as reported), route of administration: injection (SYR), anatomical location: right arm, batch number (material number: 70461-0002-01 (as reported), batch number and expiry date: not reported). On 07-Oct-2017, after 2 days of vaccination, the patient woke up with cough and sore throat. The patient felt pure sickness and experienced fever and achiness. After 14 days of sickness, the patient still had bad cough. On 14-Oct-2017, the throat culture was performed, results were found to be negative, but the throat was very raw. On an unspecified date in 2017, the patient went to physician. At the time of the report, the patient had not recovered from cough and the outcome of the events sore throat, ache, raw throat, sickness and fever was unknown. The reporter assessed the case as non-serious. Non-significant case correction received 20-Mar-2018: Typo error (batch numner was changed to batch number), the word 'event' was removed before cough.
Sex: M
Vaccine: FLUA3
Symptoms: Contusion, Nodule
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 722810), concerns a 74-year-old, elderly male patient. The patient had received flu shots previously. The patient's current condition included allergy to sulfa and thiomersal (reported as something in eye solutions and was uncertain actual allergy). The patient's concomitant medications included losartan, simvastatin and Montelukast for unknown indications. On 11-Oct-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 179401, expiry date: not reported). On 23-Oct-2017, after 12 days of vaccination, the patient developed a knot in left arm, which turned into bruise a after few days. It was healing and returned to normal colour. At the time of this report, the patient had recovered from the events. The reporter assessed the case as non-serious.
Age: 69.0
Sex: F
Vaccine: FLUA3, PPV
Symptoms: Chills, Erythema, Pain in extremity, Peripheral swelling
Clinical narrative: This spontaneous case, reported by health care professional (other) to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 723103), concerns 69-year-old, elderly, female patient. The patient's relevant medical history, current illnesses and concomitant medications were not reported. On 19-Oct-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 178601, expiry date: not reported). On the same day, the patient was administered with PNEUMOVAX (route of administration: intramuscular, anatomical location: left arm, batch number: N020501, dose, expiry date: not reported). On 20-Oct-2017, 1 day after vaccination, the patient experienced extreme chills, redness, swelling and prolonged pain in arm. At the time of this report, outcome of all the events was unknown. The reporter assessed this case as non-serious.
Age: 68.0
Sex: F
Vaccine: FLUA3
Symptoms: Blood pressure increased, Dizziness, Palpitations
Clinical narrative: This spontaneous case, reported by Other Health Professional to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 723039), concerns a 68-year-old elderly female patient. The patient's medical history was not reported and no known allergies. The patient's concomitant medications included losartan and HCTZ for an unknown indication. On 25-Oct-2017, the patient was administered with FLUAD (dose: 0.5ml (unk as reported), route of administration: intramuscular and anatomical location: left arm, batch number: 179603). On the same day, 15 mins after vaccination, the patient felt lightheaded, dizzy and heart was racing. The patient's blood pressure was 230/120. The outcome of the events was recovered. The reporter assessed the case as non-serious.
Age: 72.0
Sex: F
Vaccine: FLUA3, PPV
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 723235), concerning a 72-year-old, elderly female patient. The patient's current conditions included: hypothyroid, hypertension and osteoporosis. It was reported that the, patient had no known drug allergies. Concomitant medications included: Hydrochlorothiazide with Irbesartan, Calcium plus vitamin D, BONIVA, and SYNTHROID for an unknown indication. On 24-Oct-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 178501, expiry date: not reported). On the same day, the patient was administered with non-company suspect drug PNEUMOVAX (dose: 1 DF, route of administration: intramuscular, anatomical location: right arm, batch number: N013521, expiry date: not reported). On the same day of vaccination, the patient developed redness, itching and swelling at the site where PNEUMOVAX 23 was injected. The patient made physician's office visit for the event. No lab test was performed. The patient had recovered from the events (injection redness, injection site itching and injection site swelling). The reporter assessed the case as non-serious.
Sex: M
Vaccine: FLUA3, PPV
Symptoms: Asthenia, Fatigue, Rash
Clinical narrative: This spontaneous case from, reported by health care professional (other) to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 723329), concerns a 67-year-old elderly male patient. The patient had no current conditions and no known allergies. The patient had a reaction (redness in arms) to an unspecified vaccine in the past. The patient's concomitant medication included Fluticasone nasal spray for unknown indication. On 26-Oct-2017, the patient was administered with FLUAD (TIV) (dose: 0.5ml, route of administration: intramuscular, anatomical location: left arm, batch number: 179523, expiry date: not reported). On the same day, the patient was also administered with non-company suspect product PNEUMOVAX (dose: 1DF, route of administration: intramuscular, anatomical location: right arm, batch number N013541, expiry date: not reported). On 27-Oct-2017, 1 day after vaccination, the patient experienced symptoms of weakness, fatigue and rash on chest and stomach. At the time of this report, the outcome of the events was unknown. The reporter assessed this case as non-serious.
Age: 72.0
Sex: M
Vaccine: FLUA3
Symptoms: Insomnia, Mobility decreased, Pain, X-ray normal
Clinical narrative: This spontaneous case, reported by healthcare professional (other) to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 723337), concerns a 72-year-old, elderly, male patient. The patient had no relevant medical history, no current illness and no known allergies. However, it was also reported that the patient's concomitant medications included Aspirin, Vitamin D, probiotic and potassium citrate for an unknown indication. On 22-Sep-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: right arm, batch number: 178701 and expiry date: not reported). On the same day, after the vaccination, (in the evening) the patient could not raise his arm. The patient also experienced trouble in sleeping due to pain for 2 nights. On 26-Oct-2017, the patient went to the physician office and Xray was done which showed no bone chips and found to be normal. At the time of this report, the outcome of the events  was unknown. The reporter assessed the events as non-serious.
Age: 70.0
Sex: M
Vaccine: FLUA3
Symptoms: Injection site pain, Insomnia, Pain
Clinical narrative: This spontaneous case, reported by other non-health professional to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 723376), concerning a 70-year-old, elderly male patient. The patient's historical condition included: prostate cancer. The patient had no current illness. Concomitant medications included: Bicalutamide, Simvastatin, Pantoprazole, Calcium and Vitamin C for an unknown indication. On 14-Oct-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml (reported as 1 dose), route of administration: intramuscular, anatomical location: right arm, batch number, expiry date: not reported). One hour after vaccination, the patient experienced pain in the right shoulder, had trouble sleeping and constant pain. On the fourth day, the constant pain subsided. However, the patient could not raise arm above his shoulder without pain and even at rest had pain. As of today, 29-Oct-2017, still could not raise his arm without pain. It was reported that, the patient made his physician's office visit. At the time of this report, the patient had not yet recovered from the events (sleep difficult, pain and injection site pain). The reporter assessed the case as non-serious.
Age: 83.0
Sex: F
Vaccine: FLUA3, PNC13
Symptoms: Blister, Erythema, Pain in extremity, Skin warm
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 723778), concerns an 83-year-old, elderly, female patient. The patient underwent mastectomy of left breast (unspecified date). The patient's historical conditions, current conditions and concomitant medications were not reported. The patient had no allergies. On 10-Oct-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: right arm, batch number: 178301 and expiry date: not reported) and non-company suspect product PREVNAR 13 (dose: 1 DF (reported as 1), route of administration: intramuscular, anatomical location: right arm, batch number: S58702 and expiry date: not reported). On 13-Oct-2017, after 3 days of vaccination, the patient complained of pain and redness in right arm. On 17-Oct-2017, after 8 days of vaccination, the patient developed blisters. On 18-Oct-2017, after 9 days of vaccination, the patient went to the clinic with large erythematous area and warmth in right arm. No blisters and open skin were observed at that time. On the same day, the patient also went to the urgent care and cause of redness and warmth was unknown. The patient was prescribed with oral steroid therapy. On an unspecified date in Oct-2017, the patient had recovered from the event blister and outcome of all other events was not reported. The reporter assessed the events as non-serious.
Age: 75.0
Sex: F
Vaccine: FLUA3
Symptoms: Faeces discoloured, Feeling abnormal, Feeling jittery, Frequent bowel movements, Hyperhidrosis
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 723809), concerns a 75-year-old, elderly female patient. The patient's current condition included allergy to penicillin. The patient had no medical history, current illness or lab data. On 26-Oct-2017, then patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 6323711-1176 (as reported), expiry date: not reported). On 27-Oct-2017, the next day of vaccination, the patient had violent shaking, sweating (described as sweating buckets and soaking through everything), frequent bowel movements and pitch-black stools. The patient was normal in every other way. The patient also felt abnormal and jittery. At the time of the report, the patient had not recovered from the events.
Age: 75.0
Sex: F
Vaccine: FLUA3
Symptoms: Tremor
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 723809), concerns a 75-year-old, elderly female patient. The patient's current condition included allergy to penicillin. The patient had no medical history, current illness or lab data. On 26-Oct-2017, then patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 6323711-1176 (as reported), expiry date: not reported). On 27-Oct-2017, the next day of vaccination, the patient had violent shaking, sweating (described as sweating buckets and soaking through everything), frequent bowel movements and pitch-black stools. The patient was normal in every other way. The patient also felt abnormal and jittery. At the time of the report, the patient had not recovered from the events.
Age: 70.0
Sex: F
Vaccine: FLUA3
Symptoms: Mobility decreased, Myalgia
Clinical narrative: This spontaneous case, reported by health care professional (other) to VAERS and initially retrieved on 20-Mar-2018 by Seqirus from VAERS (VAERS ID: 723896), concerns a 70-year-old, elderly, female patient. The patient's medical history, allergies and the concomitant medications were not reported. On 09-Oct-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml (1 as reported), route of administration: intramuscular, anatomical location: left arm, batch number: 179302 and expiry date: not reported). On 30-Oct-2017, after 22 days of vaccination, the patient experienced lot of muscle pain and difficulty while raising her arm. At the time of the report, the outcome of the events (muscle pain and myalgia) was unknown. The reporter assessed the case as non-serious.